Titre : Accident nucléaire de Fukushima

Accident nucléaire de Fukushima : Questions médicales fréquentes

Termes MeSH sélectionnés :

C-Reactive Protein
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Accident nucléaire de Fukushima : Questions médicales les plus fréquentes", "headline": "Accident nucléaire de Fukushima : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Accident nucléaire de Fukushima : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Accident nucléaire de Fukushima" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Émission de source de risque radioactif", "url": "https://questionsmedicales.fr/mesh/D018788", "about": { "@type": "MedicalCondition", "name": "Émission de source de risque radioactif", "code": { "@type": "MedicalCode", "code": "D018788", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.135.848" } } }, "about": { "@type": "MedicalCondition", "name": "Accident nucléaire de Fukushima", "alternateName": "Fukushima Nuclear Accident", "code": { "@type": "MedicalCode", "code": "D062406", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Seiji Yasumura", "url": "https://questionsmedicales.fr/author/Seiji%20Yasumura", "affiliation": { "@type": "Organization", "name": "Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan." } }, { "@type": "Person", "name": "Kenji Kamiya", "url": "https://questionsmedicales.fr/author/Kenji%20Kamiya", "affiliation": { "@type": "Organization", "name": "Fukushima Medical University Radiation Medical Science Centre for the Fukushima Health Management Survey, 1 Hikarigaoka, Fukushima City 960-1295, Japan." } }, { "@type": "Person", "name": "Tetsuya Ohira", "url": "https://questionsmedicales.fr/author/Tetsuya%20Ohira", "affiliation": { "@type": "Organization", "name": "Fukushima Medical University, Fukushima, Fukushima, Japan." } }, { "@type": "Person", "name": "Masaharu Tsubokura", "url": "https://questionsmedicales.fr/author/Masaharu%20Tsubokura", "affiliation": { "@type": "Organization", "name": "Department of Radiation Health Management, School of Medicine, Fukushima Medical University, 1 Hikariga-oka, Fukushima 960-1295, Japan." } }, { "@type": "Person", "name": "Hironori Nakano", "url": "https://questionsmedicales.fr/author/Hironori%20Nakano", "affiliation": { "@type": "Organization", "name": "Fukushima Medical University, Fukushima, Fukushima, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Diagnoses Based on C-Reactive Protein Point-of-Care Tests.", "datePublished": "2022-05-17", "url": "https://questionsmedicales.fr/article/35624645", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/bios12050344" } }, { "@type": "ScholarlyArticle", "name": "Biosensors; noninvasive method in detection of C-reactive protein (CRP).", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37498420", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10544-023-00666-y" } }, { "@type": "ScholarlyArticle", "name": "C-reactive protein isoforms as prognostic markers of COVID-19 severity.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36741367", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1105343" } }, { "@type": "ScholarlyArticle", "name": "Pleiotropic genetic architecture and novel loci for C-reactive protein levels.", "datePublished": "2022-11-14", "url": "https://questionsmedicales.fr/article/36376304", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-022-34688-6" } }, { "@type": "ScholarlyArticle", "name": "C-Reactive Protein (CRP): A poor prognostic biomarker in COVID-19.", "datePublished": "2022-11-14", "url": "https://questionsmedicales.fr/article/36451818", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1040024" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Accidents", "item": "https://questionsmedicales.fr/mesh/D000059" }, { "@type": "ListItem", "position": 5, "name": "Émission de source de risque radioactif", "item": "https://questionsmedicales.fr/mesh/D018788" }, { "@type": "ListItem", "position": 6, "name": "Accident nucléaire de Fukushima", "item": "https://questionsmedicales.fr/mesh/D062406" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Accident nucléaire de Fukushima - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Accident nucléaire de Fukushima", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Accident nucléaire de Fukushima", "description": "Comment diagnostiquer une exposition aux radiations ?\nQuels tests sont utilisés pour évaluer la contamination radioactive ?\nQuels symptômes indiquent une exposition aiguë ?\nComment évaluer les effets à long terme de l'accident ?\nQuels examens sont recommandés après l'accident ?", "url": "https://questionsmedicales.fr/mesh/D062406?mesh_terms=C-Reactive+Protein&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Accident nucléaire de Fukushima", "description": "Quels sont les symptômes d'une exposition chronique ?\nComment se manifestent les brûlures dues aux radiations ?\nQuels troubles psychologiques peuvent survenir ?\nQuels signes indiquent une contamination interne ?\nComment les enfants réagissent-ils à l'exposition ?", "url": "https://questionsmedicales.fr/mesh/D062406?mesh_terms=C-Reactive+Protein&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Accident nucléaire de Fukushima", "description": "Comment prévenir l'exposition aux radiations ?\nQuelles mesures de sécurité sont mises en place ?\nComment informer la population sur les risques ?\nQuels sont les rôles des autorités sanitaires ?\nComment gérer les déchets radioactifs ?", "url": "https://questionsmedicales.fr/mesh/D062406?mesh_terms=C-Reactive+Protein&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Accident nucléaire de Fukushima", "description": "Quels traitements sont disponibles pour l'exposition aiguë ?\nComment traiter la contamination radioactive ?\nQuels soins sont recommandés pour les brûlures ?\nComment gérer les effets psychologiques ?\nQuels suivis médicaux sont nécessaires après traitement ?", "url": "https://questionsmedicales.fr/mesh/D062406?mesh_terms=C-Reactive+Protein&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Accident nucléaire de Fukushima", "description": "Quelles sont les complications à long terme ?\nComment l'accident affecte-t-il la santé mentale ?\nQuels impacts sur la reproduction sont possibles ?\nComment l'environnement est-il affecté ?\nQuels sont les risques pour les travailleurs de la centrale ?", "url": "https://questionsmedicales.fr/mesh/D062406?mesh_terms=C-Reactive+Protein&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Accident nucléaire de Fukushima", "description": "Quels facteurs augmentent le risque de cancer ?\nComment l'alimentation influence-t-elle le risque ?\nQuel rôle joue la génétique dans les risques ?\nComment le stress influence-t-il la santé ?\nQuels sont les risques pour les populations vulnérables ?", "url": "https://questionsmedicales.fr/mesh/D062406?mesh_terms=C-Reactive+Protein&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une exposition aux radiations ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des évaluations cliniques sont utilisés pour diagnostiquer l'exposition." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la contamination radioactive ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des dosimètres et des compteurs Geiger sont utilisés pour mesurer la contamination." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aiguë ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Nausées, vomissements, fatigue et brûlures cutanées peuvent indiquer une exposition aiguë." } }, { "@type": "Question", "name": "Comment évaluer les effets à long terme de l'accident ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des études épidémiologiques et des suivis médicaux sont nécessaires pour évaluer les effets." } }, { "@type": "Question", "name": "Quels examens sont recommandés après l'accident ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des examens de santé réguliers et des tests de dépistage de cancers sont recommandés." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition chronique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue persistante, troubles respiratoires et cancers peuvent survenir après une exposition chronique." } }, { "@type": "Question", "name": "Comment se manifestent les brûlures dues aux radiations ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les brûlures peuvent apparaître comme des rougeurs, des cloques ou des lésions cutanées." } }, { "@type": "Question", "name": "Quels troubles psychologiques peuvent survenir ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Anxiété, dépression et stress post-traumatique sont fréquents après l'accident." } }, { "@type": "Question", "name": "Quels signes indiquent une contamination interne ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes tels que des douleurs abdominales et des vomissements peuvent indiquer une contamination." } }, { "@type": "Question", "name": "Comment les enfants réagissent-ils à l'exposition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes plus graves et un risque accru de cancers." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux radiations ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les zones contaminées et utiliser des équipements de protection sont essentiels." } }, { "@type": "Question", "name": "Quelles mesures de sécurité sont mises en place ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles de sécurité, des alertes et des zones d'évacuation sont établis." } }, { "@type": "Question", "name": "Comment informer la population sur les risques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des formations sont essentielles pour sensibiliser la population." } }, { "@type": "Question", "name": "Quels sont les rôles des autorités sanitaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les autorités surveillent la santé publique et mettent en œuvre des mesures de protection." } }, { "@type": "Question", "name": "Comment gérer les déchets radioactifs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets doivent être stockés en toute sécurité et traités selon des normes strictes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'exposition aiguë ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des soins d'urgence, des transfusions sanguines et des traitements symptomatiques sont nécessaires." } }, { "@type": "Question", "name": "Comment traiter la contamination radioactive ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des agents chélateurs peuvent être administrés pour éliminer les radionucléides du corps." } }, { "@type": "Question", "name": "Quels soins sont recommandés pour les brûlures ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des soins locaux, des antibiotiques et des greffes de peau peuvent être nécessaires." } }, { "@type": "Question", "name": "Comment gérer les effets psychologiques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies psychologiques et des groupes de soutien sont recommandés pour la gestion du stress." } }, { "@type": "Question", "name": "Quels suivis médicaux sont nécessaires après traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers pour surveiller les effets à long terme et les cancers sont essentiels." } }, { "@type": "Question", "name": "Quelles sont les complications à long terme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les cancers, les maladies cardiovasculaires et les troubles endocriniens peuvent survenir." } }, { "@type": "Question", "name": "Comment l'accident affecte-t-il la santé mentale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "L'anxiété et la dépression peuvent persister longtemps après l'accident." } }, { "@type": "Question", "name": "Quels impacts sur la reproduction sont possibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies congénitales et des problèmes de fertilité peuvent être des conséquences." } }, { "@type": "Question", "name": "Comment l'environnement est-il affecté ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La contamination des sols et des eaux peut avoir des effets durables sur l'écosystème." } }, { "@type": "Question", "name": "Quels sont les risques pour les travailleurs de la centrale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs peuvent être exposés à des niveaux élevés de radiations, augmentant les risques de cancer." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de cancer ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, le sexe et l'exposition antérieure aux radiations sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en iode peut réduire le risque de cancer de la thyroïde après exposition." } }, { "@type": "Question", "name": "Quel rôle joue la génétique dans les risques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des prédispositions génétiques peuvent augmenter la susceptibilité aux effets des radiations." } }, { "@type": "Question", "name": "Comment le stress influence-t-il la santé ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut aggraver les effets de l'exposition aux radiations sur la santé mentale." } }, { "@type": "Question", "name": "Quels sont les risques pour les populations vulnérables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants, les femmes enceintes et les personnes âgées sont plus à risque d'effets néfastes." } } ] } ] }

Sources (10000 au total)

C-Reactive Protein (CRP): A poor prognostic biomarker in COVID-19.

The COVID-19 pandemic continues to be rampant with considerable morbidity and mortality worldwide since its emergence in December 2019. Several studies have focused on identifying different predictive... We conducted a retrospective, monocentric, descriptive and analytical study in the Department of Anesthesia and Intensive Care of the Mohammed VI University Hospital of Oujda, Morocco, between March 2... Among our 1035 included patients, 291 patients with had a CRP<100mlg/L (group 1) and 744 presented a CRP level equal or superior to 100mg/L (group 2). Lung parenchymal involvement was more severe or e... Given the high contagiousness of the virus and the emergence of several variants, the management of the COVID-19 pandemic has focused more on prevention through vaccination against the virus, but also...

The Association of Prenatal C-Reactive Protein Levels With Childhood Asthma and Atopy.

The pathogenesis of childhood asthma is complex, and determinants of risk may begin in utero.... To describe the association of systemic prenatal inflammation, measured by plasma C-reactive protein (CRP), with childhood asthma, eczema, and allergic rhinitis.... A total of 522 maternal-offspring pairs from the Vitamin D Antenatal Asthma Reduction Trial were included. Prenatal plasma CRP level was measured between 10 and 18 weeks of gestation and between 32 an... Elevated early and late prenatal CRP and an increase in CRP from early to late pregnancy were associated with asthma by age 6 years (early: adjusted odds ratio [aOR], 1.76, 95% CI, 1.12-2.82, P = .02;... Higher prenatal CRP and an increase in CRP from early to late pregnancy are associated with childhood asthma. Systemic inflammation during pregnancy associated with modifiable maternal characteristics...

An umbrella review of meta-analyses on diagnostic accuracy of C-reactive protein.

Multiple studies and meta-analyses have reported the diagnostic value of C-reactive protein (CRP) in several diseases. However, the precision, and influence of potential bias regarding the diagnostic ... We performed an umbrella review of diagnostic test accuracy studies of CRP for diseases by searching PubMed, Embase, China National Knowledge Infrastructure, and WanFang databases up to March 7, 2021.... Seventy-four meta-analyses were included, with 13 diseases classified according to the International Classification of Diseases-11 (ICD-11). The methodological quality of the included meta-analyses wa... The diagnostic accuracy of CRP for multiple diseases has been extensively studied; however, most studies have low methodological quality. Evidence indicates that CRP has a relatively greater diagnosti...

The Role of C-Reactive Protein in the Prognosis of Prostate Cancer: A Meta-Analysis.

To investigate the role of C-reactive protein (CRP) in the prognosis of prostate cancer (PCa).... The studies related to C-reactive protein and prostate cancer were searched by computer, including PubMed and Web of Science. The retrieval time was from the establishment of the database to August 20... In the initial examination, 432 articles were obtained. After removing the duplicate articles, reading the abstract and theme, and then reading the full text, 12 articles finally met the inclusion cri... CRP levels are associated with PCa patients' OS. High CRP levels have an elevated incidence of PCa, but there was no obvious distinction in circulating CRP levels between patients with prostate cancer...